Zoetis Inc. (NYSE:ZTS) Stock Position Raised by Kestra Private Wealth Services LLC

Kestra Private Wealth Services LLC lifted its stake in shares of Zoetis Inc. (NYSE:ZTS) by 6.5% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 82,692 shares of the company’s stock after purchasing an additional 5,027 shares during the period. Kestra Private Wealth Services LLC’s holdings in Zoetis were worth $13,473,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of ZTS. Mizuho Securities USA LLC grew its stake in Zoetis by 13,726.9% during the 3rd quarter. Mizuho Securities USA LLC now owns 4,865,000 shares of the company’s stock valued at $950,524,000 after acquiring an additional 4,829,815 shares in the last quarter. International Assets Investment Management LLC increased its stake in Zoetis by 41,235.7% in the 3rd quarter. International Assets Investment Management LLC now owns 939,974 shares of the company’s stock valued at $183,652,000 after buying an additional 937,700 shares during the period. Assenagon Asset Management S.A. lifted its position in Zoetis by 296.9% in the 4th quarter. Assenagon Asset Management S.A. now owns 889,444 shares of the company’s stock worth $144,917,000 after buying an additional 665,331 shares in the last quarter. Nordea Investment Management AB boosted its stake in shares of Zoetis by 38.3% during the 4th quarter. Nordea Investment Management AB now owns 2,065,514 shares of the company’s stock valued at $336,266,000 after buying an additional 572,511 shares during the period. Finally, Holocene Advisors LP purchased a new position in shares of Zoetis during the 3rd quarter valued at $110,809,000. 92.80% of the stock is owned by hedge funds and other institutional investors.

Zoetis Stock Performance

Shares of NYSE ZTS opened at $171.37 on Friday. Zoetis Inc. has a 12 month low of $144.80 and a 12 month high of $200.53. The company has a market cap of $77.32 billion, a P/E ratio of 32.21, a P/E/G ratio of 2.77 and a beta of 0.90. The business’s 50 day moving average is $169.26 and its two-hundred day moving average is $179.22. The company has a quick ratio of 2.27, a current ratio of 3.69 and a debt-to-equity ratio of 1.26.

Zoetis Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 3rd. Investors of record on Monday, April 21st will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.17%. The ex-dividend date of this dividend is Monday, April 21st. Zoetis’s payout ratio is currently 37.59%.

Wall Street Analyst Weigh In

Several analysts recently issued reports on the company. Stifel Nicolaus reduced their price objective on Zoetis from $210.00 to $180.00 and set a “buy” rating for the company in a research report on Tuesday, January 7th. Morgan Stanley lowered their price target on Zoetis from $248.00 to $243.00 and set an “overweight” rating for the company in a research note on Wednesday, January 29th. UBS Group assumed coverage on shares of Zoetis in a research report on Monday, December 9th. They set a “neutral” rating and a $196.00 price objective on the stock. Leerink Partners initiated coverage on shares of Zoetis in a research note on Monday, December 2nd. They set an “outperform” rating and a $215.00 price target on the stock. Finally, Leerink Partnrs raised shares of Zoetis to a “strong-buy” rating in a research note on Monday, December 2nd. One research analyst has rated the stock with a hold rating, ten have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Buy” and an average target price of $215.00.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.